State of diagnostics and therapy of inflammatory cardiomyopathie;Stand der diagnostik und therapie der inflammatorischen kardiomyopathie

Internist

Volumn 49, Issue 1, 2008, Pages 7-16

  Schultheiss, H P ^a   Kuhl U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiotropic viruses; Inflammatory cardiomyopathy; Myocarditis; Viral myocarditis

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CORTISONE; GANCICLOVIR; METHYLPREDNISOLONE;

CARDIOMYOPATHY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HEART MUSCLE; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CARDIOMYOPATHY; MOLECULAR BIOLOGY; MYOCARDITIS; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; VIRUS MYOCARDITIS;

BACTERIAL INFECTIONS; CARDIOLOGY; HUMANS; MYCOSES; MYOCARDITIS; VIRUS DISEASES;

EID: 39649107559     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1966-y     Document Type: Review

References (41)

1. Anderson JL et al. (1987) Immunosuppressive treatment of myocardial inflammatory disease - initial experience and future trials to define indications for therapy. Eur Heart J 8 (Suppl): 263-266
2. Aoyama N, Izumi T, Hiramori K et al. (2002) National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 66: 133-144
3. Archard LC, Khan MA, Soteriou BA et al. (1998) Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29: 578-584
4. Aretz HT, Billingham ME, Edwards WD et al. (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1: 3-14
5. Bowles NE, Ni J, Kearney DL et al. (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466-472
6. Cooper LT, Baughman KL, Feldman AM et al.; American Heart Association; American College of Cardiology; European Society of Cardiology(2007) The Role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116: 2216-2233
7. Cooper LT, Berry GJ, Rizeq M, Schroeder JS (1995) Giant cell myocarditis. J Heart Lung Transplant 14: 394-401
8. D'Ambrosio A, Patti G, Manzoli A,et al. (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85: 499-504
9. Dec GW, Palacios IF, Fallon JT et al. (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312: 885-890
10. Edwards WD, Holmes DR, Reeder GS (1982) Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy: quantitative criteria for light microscopy. Mayo Clin Proc 57: 419-425
11. Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343: 1388-1398
12. Felker GM, Thompson RE, Hare JM et al. (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342: 1077-1084
13. Figulla HR, Stille-Siegener M, Mall G et al. (1995) Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 25: 1170-1175
14. Frustaci A, Chimenti C, Calabrese F et al. (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107: 857-863
15. Grogan M, Redfield MM, Bailey KR et al. (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26: 80-84
16. Hobbs RE, Pelegrin D, Ratliff NB et al. (1989) Lymphocytic myocarditis and dilated cardiomyopathy: treatment with immunosuppressive agents. Cleve Clin J Med 56: 628-635
17. Hosenpud JD, McAnulty JH, Niles NR (1985) Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol 6: 797-801
18. Jones SR, Herskowitz A, Hutchins GM, Baughman KL (1991) Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 68: 370-376
19. Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75: 295-300
20. Kühl U, Pauschinger M, Noutsias M et al. (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with.,idiopathic" left ventricular dysfunction. Circulation 111: 887-893
21. Kühl U, Pauschinger M, Schwimmbeck PL et al. (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793-2798
22. Kühl U, Pauschinger M, Seeberg B et al. (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970
23. Kühl U, Strauer BE, Schultheiss HP (1994) Methylprednisolone in chronic myocarditis. Postgrad Med J 70 (Suppl 1): S35-42
24. Liu PP, Mason JW (2001) Advances in the understanding of myocarditis. Circulation 104: 1076-1082
25. Magnani JW, Danik HJ, Dec GW, DiSalvo TG(2006) Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathological, clinical, and hemodynamic predictors.Am Heart J 151: 463-470
26. Maisch B, Schönian U, Hengstenberg C et al. (1994) Immunosuppressive treatment in autoreactive myocarditis - results from a controlled trial. Postgrad Med J 70 Suppl 1: S29-34
27. Maron BJ, Towbin JA, Thiene G et al.; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention (2006) Contemporary definitions and classification of cardiomyopathies. Circulation 113: 1807-1816
28. Mason JW, O'Connell JB, Herskowitz A et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333: 269-275
29. Matsumori A, Matoba Y, Sasayama S (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92: 2519-2525
30. McCarthy RE, Boehmer JP, Hruban RH et al. (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342: 690-695
31. McNamara DM, Holubkov R, Starling RC et al. (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103: 2254-2259
32. Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131
33. Parrillo JE, Cunnion RE, Epstein SE et al. (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321: 1061-1068
34. Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al. (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99: 1348-1354
35. Pauschinger M, Doerner A, Kuehl U et al. (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99: 889-895
36. Pulerwitz TC, Cappola TP, Felker GM et al. (2004) Mortality in primary and secondary myocarditis. Am Heart J 147: 746-750
37. Richardson P, McKenna W, Bristow M et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841-842
38. Schultheiss HP, Noutsias M, Kühl U et al. (2005) [Cardiomyopathies. I: classification of cardiomyopathies - dilated cardiomyopathy]. Internist (Berl) 46: 1245-1256
39. Why HJ, Meany BT, Richardson PJ et al. (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89: 2582-2589
40. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104: 39-45
41. Zee-Cheng CS, Tsai CC, Palmer DC et al. (1984) High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol 3: 63-70